Targeting PTBP3‐Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis
Advanced Science · 2025
DOI: 10.1002/advs.202415983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yajing Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu Province, 215031, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Polypyrimidine Tract-Binding Protein, Alternative Splicing, Peritoneal Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Gusu Health Talents Cultivation Program, China, "Qinglan Project" in Jiangsu Colleges and Universities.
Abstract (Originalsprache)
Numerous aberrant splicing events are implicated in tumor progression, yet comprehensive reports on splicing factors and events associated with peritoneal metastasis in gastric cancer (GCPM) are lacking. In this study, PTBP3 is found to be significantly overexpressed in peritoneal metastatic tissues of gastric cancer compared to primary tumor tissues, and higher PTBP3 expression correlates with poorer prognosis. Using gastric cancer cells and patient‐derived organoids (PDO), the role of PTBP3 in promoting tumor invasion and proliferation is investigated. Mechanistically, through full‐length transcriptome sequencing, PTBP3 mediates exon 4 skipping in its target gene COX11, leading to shorter transcripts that impair COX11 protein function, reducing mitochondrial copper content and enabling tumor cells to evade cuproptosis. Antisense oligonucleotide (ASO) drugs targeting the short COX11 transcripts effectively degrade mRNA, disrupting copper homeostasis. In PDO‐based xenograft models, exogenous copper ionophores combined with ASO drugs induce excessive copper accumulation in mitochondria, triggering proteotoxic stress and cuproptosis. Overall, PTBP3‐mediated exon 4 skipping in COX11 pre‐mRNA is critical for tumor cell survival and progression in GCPM, offering potential therapeutic strategies targeting copper metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu Province, 215031, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu Province, 215031, China.
ORCID-Profile: Yajing Zhou
Förderung
- National Natural Science Foundation of China
- Gusu Health Talents Cultivation Program, China
- "Qinglan Project" in Jiangsu Colleges and Universities
- Boxi Youth Natural Science Foundation of the First Affiliated Hospital of Soochow University
- The Youth Science and Technology of Suzhou Science and Education Project
- The Natural Science Foundation of Jiangsu Province
- The Special Project of Diagnosis and Treatment Technology for Clinical Key Diseases in Suzhou
Zitieren
APA
Zhou, Y., Dong, C., Shen, X., Wang, P., Chen, T., Li, W., Sun, X., Li, P., Xu, C., Duan, K., Li, D., & Zhou, J. (2025). Targeting PTBP3‐Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis. Advanced Science. https://doi.org/10.1002/advs.202415983
Vancouver
Zhou Y, Dong C, Shen X, Wang P, Chen T, Li W, et al. Targeting PTBP3‐Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis. Advanced Science. 2025. doi:10.1002/advs.202415983
BibTeX
@article{Zhou2025,
author = {Zhou, Yajing and Dong, Chao and Shen, Xiaochun and Wang, Pengbo and Chen, Tao and Li, Weikang and Sun, Xiaotong and Li, Peiyuan and Xu, Chengxiang and Duan, Kaipeng and Li, Dongbao and Zhou, Jin},
title = {Targeting PTBP3‐Mediated Alternative Splicing of COX11 Induces Cuproptosis for Inhibiting Gastric Cancer Peritoneal Metastasis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415983}
}
EUVIMED